UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...
By Farnaz Fassihi Quebec says a new policy to charge some students higher tuition at top universities in Montreal is needed to preserve the province’s French identity. By Vjosa Isai and Nasuna ...
By Patrick Kingsley Quebec says a new policy to charge some students higher tuition at top universities in Montreal is needed to preserve the province’s French identity. By Vjosa Isai and ...
Do some prep work before appointments. It’s good to know exactly which points you want ... Alternatively, national groups like the Patient Advocate Foundation, or local organizations like New York’s ...